Robinson Chandler bought MNPR

September 30, 2025 · Form 4 insider transaction

Robinson Chandler bought 8,726 shares of MONOPAR THERAPEUTICS INC, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.

Direction

Acquired (buy-side)

8,726

Price

N/A

Total value

N/A

InsiderRobinson Chandler

Role—

CompanyMONOPAR THERAPEUTICS INC (MNPR)

SecurityCommon Stock

Transaction codeM — Option exercise

Transaction dateSeptember 30, 2025

Filing dateOctober 2, 2025

Shares owned after82,198

OwnershipDirect

10b5-1 planNo

AmendedNo

Footnotes

Represents shares acquired on vesting and settlement of restricted stock units.

View the original Form 4 on SEC EDGAR